Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June–July 2021: A population-based cross-sectional study

Adaptive immunity to SARS-CoV-2 and COVID-19

(2021) Alessandro Sette et al.   CELL

SARS-CoV-2 seroprevalence survey estimates are affected by anti-nucleocapsid antibody decline

(2021) Shelly Bolotin et al.   JOURNAL OF INFECTIOUS DISEASES

The great escape? SARS-CoV-2 variants evading neutralizing responses

(2021) Jérémie Prévost et al.   Cell Host & Microbe

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial

(2021) Raches Ella et al.   LANCET INFECTIOUS DISEASES

Clinical validation of the Siemens quantitative SARS-CoV-2 spike IgG assay (sCOVG) reveals improved sensitivity and a good correlation with virus neutralization titers

(2021) Christian Irsara et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

SARS-CoV-2 sero-prevalence among general population and healthcare workers in India, December 2020 - January 2021

(2021) Manoj V. Murhekar et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)

(2021) Victoria Jane Hall et al.   LANCET

Persistence of humoral immune response to SARS-CoV-2 up to 7 months post-infection: Cross-sectional study, South India, 2020–21

(2021) Jeromie Wesley Vivian Thangaraj et al.   JOURNAL OF INFECTION

SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans

(2021) Jackson S. Turner et al.   NATURE

Title: Antibody Response after First and Second-dose of ChAdOx1-nCOV (CovishieldTM®) and BBV-152 (CovaxinTM®) among Health Care Workers in India: The Final Results of Cross-sectional Coronavirus Vaccine-induced Antibody Titre (COVAT) study

(2021) Awadhesh Kumar Singh et al.   VACCINE

Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom

(2021) Jia Wei et al.   Nature Microbiology

Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, India

(2021) Mahesh S. Dhar et al.   SCIENCE

Adjusting Coronavirus Prevalence Estimates for Laboratory Test Kit Error

(2020) Christopher T Sempos et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients

(2020) Anita S. Iyer et al.   Science Immunology